----- List Price: $80.00 (Incl. US Domestic Shipping Fee)
Reference Literature
- Method for producing cardiomyocyte population from pluripotent stem cells. Patent Publication No. WO2016043168 A1. 2017-6-22
- Israeli-Rosenberg et al, Circ. Res. 114: 572-586, 2014
- Nishiuchi et al, Matrix Biol. 25(3): 189-97, 2006
- Taniguchi et al, J. Biol. Chem. 284(12): 7820-31, 2009
Product Basics:
iMatrix-221 is a recombinant E8 fragment that retains full integrin binding activity of Laminin-221. iMatrix-221 is a highly purified and refined product of human recombinant laminin-221 (E8 fragment).
FOR RESEARCH USE ONLY, NOT FOR USE IN DIAGNOSTIC PROCEDURES